Journals / Okmeydanı Tıp Dergisi / 2016 / Cilt: 32 - Sayı: 2

Concomitant Gynecological Pathologies and Risk Factors for Adenomyosis

Adenomiyozise Eşlik Eden Jinekolojik Patolojiler ve Adenomiyozis İçin Risk Faktörleri

Pages
88–91
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Since endometrial hyperplasia and polyps commonly accompany this disorder, patients suspected of having adenomyosis should undergo endometrial sampling.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To determine the risk factors for adenomyosis and to assess its association with coexisting gynecologic pathologies.
📊
Key Findings & Data:Material and Methods: The present study was performed retrospectively by analyzing the medical records of 601 patients who underwent hysterectomy for benign indications at a tertiary referral center between 2012 and 2015.
💡
Conclusion & Impact:Since endometrial hyperplasia and polyps commonly accompany this disorder, patients suspected of having adenomyosis should undergo endometrial sampling.
🔬Design:Research Article
📍Scope:2012 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: To determine the risk factors for adenomyosis and to assess its association with coexisting gynecologic pathologies. Material and Methods: The present study was performed retrospectively by analyzing the medical records of 601 patients who underwent hysterectomy for benign indications at a tertiary referral center between 2012 and 2015. According to final pathology reports, 236 patients with adenomyosis and 365 patients without adenomyosis were included in the study. The study groups were compared in terms of surgery indications, demographic and reproductive characteristics, and accompanying pathologies. Results: The most common indications for hysterectomy were leiomyoma (56.7%) and uterine prolapse (20.9%). While leiomyoma was the most common pathology that accompanied adenomyosis, endometrial polyps and hyperplasia were also more common in comparison to the patients in control group. The age group in which adenomyosis was most frequently encountered was between 40 and 49 years. History of prior cesarean section, abortion and uterine curettage were found to be risk factors for adenomyosis development. Conclusions: Adenomyosis should be included in differential diagnosis, especially in women older than 40 years of age, who present with menometrorrhagia and chronic pelvic pain. Previous cesarean section, abortion and curettage are risk factors for adenomyosis. Since endometrial hyperplasia and polyps commonly accompany this disorder, patients suspected of having adenomyosis should undergo endometrial sampling.

Özet

Amaç: Çalışmanın amacı adenomiyozis için risk faktörlerinin saptanması ve beraberinde eşlik eden jinekolojik patolojilerle ilişkisinin değerlendirilmesidir. Gereç ve Yöntem: Çalışmamız, 2012 ve 2015 tarihleri arasında 3. basamak referans merkez olan hastanemizde benign nedenlerle histerektomi yapılmış olan 601 hastanın dosyalarının retrospektif olarak taranmasıyla oluşturulmuştur. Histopatolojik inceleme sonucu çalışmaya 236 adenomiyozisi bulunan ve 365 adenomiyozisi bulunmayan olgu dâhil edilmiştir. Gruplar operasyon endikasyonları, demografik ve reprodüktif özellikler ile eşlik eden patolojiler açısından karşılaştırılmıştır.Bulgular: Altı yüz bir olgunun değerlendirildiği çalışmamızda, leiomiyoma (%56,7) ve desensus uterin (%20,9) en sık operasyon endikasyonlarını oluşturmaktaydı. Adenomiyozise en sık eşlik eden patolojiler leiomiyoma iken, endometriyal polip ve hiperplazinin kontrol grubuna göre daha yüksek oranda beraberlik gösterdiği saptandı. Adenomiyozisin en sık saptandığı yaş grubu 40-49 yaş olarak bulundu. Geçirilmiş sezaryen, abortus ve küretajın adenomiyozis için bir risk faktörü olduğu gözlendi.Sonuç: Özellikle tedaviye dirençli menometroraji ve kronik pelvik ağrısı bulunan 40 yaş üstü hastalarda ayırıcı tanıda adenomiyozis akla gelmelidir. Geçirilmiş sezaryen, abort ve küretaj adenomiyozis için risk faktörüdür. Endometriyal hiperplazi ve polipin de sıklıkla eşlik etmesi nedeniyle adenomiyozis olduğu düşünülen hastalara endometriyal örnekleme yapılması gerekmektedir.

🔖

Cite This Article

SEÇKİN, K. D., YÜCEL, B., KARSLI, M. F., SOYDAR, A., ÇELİK, H. G., KIYAK, H., KOÇBIYIK, A., YILDIRIM, G. (2016). Concomitant Gynecological Pathologies and Risk Factors for Adenomyosis. Okmeydanı Tıp Dergisi, Cilt: 32 - Sayı: 2, 88–91. https://ajindex.com/articles/291737

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Zaloudek C and Hendrickson MR. Mesenchymal tumors of the uterus. In Blausteins' pathology of the female genital tract. Kurman RJ ed. Fifth edition 2002:561
  2. Young RH, Treger T, Scully RE. Atypical polypoid adenomyoma of the uterus: a report of 27 cases. Am J Clin Pathol 1986;139:86-90
  3. Gambone JC, Reiter RC, Lench JB, et al. The impact of a quality assurance process on the frequency and confirmation rate of hysterectomy. Am J Obstet Gynecol 1990;163:545-50.
  4. Chrysostomou M, Akalestos G, Kallistros S, et al. Incidence of adenomyosis uteri in a Greek population. Acta Obstet Gynecol Scand 1991;70:441-4.
  5. Owolabi TO, Strickler RC. Adenomyosis: a neglected diagnosis. Obstet Gynecol 1977;50:424-7
  6. Vercellini P, Ragni G, Trespidi L, et al. Adenomyosis: a deja vu? Obstet Gynecol Surv 1993;48:789-94.
  7. Kunz G, Beil D, Huppert P, et al. Adenomyosis in endometriosis prevalence and impact on fertility. Evidence from magnetic resonance imaging. Hum Reprod 2005;20:2309-16.
  8. Bergholt T, Eriksen L, Berendt N, et al. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod 2005;16(11):2418-21
  9. Parazzini F, Vercellini P, Panazza S, et al. Risk factors for adenomyosis. Hum Rep Rod 1997;12(6):1275-9.
  10. Çakmak B, Özsoy Z, Hısım Y ve ark. Benign endikasyonlar nedeniyle uygulanan histerektomi materyallerinde adenomyozis sıklığı. Çağdaş Tıp Dergisi 2012;2:158-61
  11. Yeniel O, Cirpan T, Ulukus M, et al. Adenomyosis: prevalence, risk factors, symptoms and clinical findings. Clin Exp Obstet Gynecol 2007;34(3):163-7
  12. Levgur M, Abadi MA, Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet Gynecol 2000;95(5):688-91.
  13. Templeman C, Marshall SF, Ursin G, et al. Adenomyosis and endometriosis in the California Teachers Study. Fertil Steril 2008;90(2):415-24.
  14. Jaslow CR. Uterine factors. Obstet Gynecol Clin North Am 2014;41(1):57-86.
  15. Shrestha A. Risk factors for adenomyosis. J Nepal Health Res Counc 2012;10(22):229-33
  16. Genc M, Genc B, Cengiz H. Adenomyosis and accompanying gynecological pathologies. Arch Gynecol Obstet 2015;291:877-81. http://dx.do